Leqembi, first FDA-approved Alzheimer's drug, faces EMA rejection, but shares could potentially surge soon. See why I rate ...

Having these warning signs checked out could provide an opportunity to delay or even prevent the onset of dementia or ...

In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as ...

Late-breaking oral presentation to highlight safety and efficacy of LX1001 across four dose cohorts NEW YORK, Oct. 22, 2024 ...

Alzheimer’s disease is the leading cause of dementia in the UK. It’s a complex, challenging, and devastating condition that causes a gradual decline in a person’s cognition, including memory and ...

On November 28, 1520, Portuguese navigator Ferdinand Magellan reached the Pacific Ocean after passing through the South American strait that now bears his name.

A study suggests that menopausal hormone therapy (MHT) might have moderate effects on brain health, but this depends on past ...

BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological ...

Dr. Gary Deng of the Integrative Medicine Service helps separate the hype from the proven health benefits of mushroom ...

An author of the 1973 American Psychiatric Association standard says it was never meant to stop doctors from expressing their ...

Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, has released a new Conversations video ...

Her transfixing performance in “Pru Payne” at SpeakEasy Stage Company is a worthy addition to MacDonald’s large and varied ...